Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma

Carcinogenesis

Volumn 31, Issue 9, 2010, Pages 1516-1522

  Wang, Yun Chu ^a   Chen, Yu Ling ^a   Yuan, Ray Hwang ^b   Pan, Hung Wei ^b   Yang, Wan Ching ^a,b   Hsu, Hey Chi ^a,b   Jeng, Yung Ming ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; HIGH MOBILITY GROUP A2 PROTEIN; LIN 28 PROTEIN; LIN 28B PROTEIN; MICRORNA; MICRORNA 98; MYC PROTEIN; PROTEIN LET 7; REGULATOR PROTEIN; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CARCINOGENICITY; CELL INVASION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DISEASE SEVERITY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGA2 PROTEIN; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS; YOUNG ADULT;

EID: 77956270554     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq107     Document Type: Article

References (40)

1. El-Serag,H.B. et al. (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-2576.
2. Yu,M.C. et al. (2000) Epidemiology of hepatocellular carcinoma. Can. J. Gastroenterol., 14, 703-709.
3. Schafer,D.F. et al. (1999) Hepatocellular carcinoma. Lancet, 353, 1253-1257.
4. Hsu,H.C. et al. (2000) β-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am. J. Pathol., 157, 763-770.
5. Hsu,H.C. et al. (1994) Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinoma. Hepatology, 19, 122-128.
6. Ying,S.Y. et al. (2008) The microRNA (miRNA): overview of the RNA genes that modulate gene function. Mol. Biotechnol., 38, 257-268.
7. Croce,C.M. (2009) Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet., 10, 704-714.
8. Büssing,I. et al. (2008) Let-7 microRNAs in development, stem cells and cancer. Trends Mol. Med., 14, 400-409.
9. Johnson,S.M. et al. (2005) RAS is regulated by the let-7 microRNA family. Cell, 120, 635-647.
10. Lee,Y.S. et al. (2007) The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev., 21, 1025-1030.
11. Sampson,V.B. et al. (2007) MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res., 67, 9762-9770.
12. Kumar,M.S. et al. (2008) Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc. Natl Acad. Sci. USA, 105, 3903-3908.
13. Akao,Y. et al. (2006) let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol. Pharm. Bull., 29,903-906.
14. Gramantieri,L. et al. (2007) Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res., 67, 6092-6099.
15. Viswanathan,S.R. et al. (2008) Selective blockade of microRNA processing by Lin-28. Science, 320, 97-100.
16. Heo,I. et al. (2008) Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol. Cell, 32, 276-284.
17. Heo,I. et al. (2009) TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell, 138, 696-708.
18. Moss,E.G. et al. (1997) The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cell, 88, 637-646.
19. Moss,E.G. et al. (2003) Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites. Dev. Biol., 258, 432-442.
20. Yu,J. et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917-1920.
21. West,J.A. et al. (2009) A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature, 460, 909-913.
22. Guo,Y. et al. (2006) Identification and characterization of Lin-28 homolog B (LIN28B) in human hepatocellular carcinoma. Gene, 384, 51-61.
23. Lu,L. et al. (2009) Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II. Eur. J. Cancer, 45, 2212-2218.
24. Viswanathan,S.R. et al. (2009) Lin28 promotes transformation and is associated with advanced human malignancies. Nat. Genet., 41, 843-848.
25. Edmonson,H.A. et al. (1954) Primary carcinoma of the liver: a study of 100 among 489,000 necropsies. Cancer (Phila.), 7, 462-503.
26. Fleming,I.D. et al. (1997) Liver AJCC Cancer Staging Manual. 5th edn. Lippincott-Raven, Philadelphia, PA, 5th edn98-126.
27. Vincent,S. et al. (1993) S26 ribosomal protein RNA: an invariant control for gene regulation experiments in eucaryotic cells and tissues. Nucleic Acids Res., 21, 1498.
28. Yang,M.H. et al. (2009) Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology, 50, 1464-1474.
29. Scharf,J.G. et al. (2003) The role of the IGF axis in hepatocarcinogenesis. Horm. Metab. Res., 35, 685-693.
30. Thuault,S. et al. (2006) Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. J. Cell Biol., 17, 175-183.
31. CIP1attenuates Ras-and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proc. Natl Acad. Sci. USA, 106, 19035-19039.
32. Graham,T.R. et al. (2008) Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res., 68, 2479-2488.
33. Kim,H.J. et al. (2007) Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail. Mol. Cell. Biol., 27, 3165-3175.
34. Chang,T.C. et al. (2009) Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc. Natl Acad. Sci. USA, 106, 3384-3389.
35. Alexia,C. et al. (2006) Insulin-like growth factor-I stimulates H4II rat hepatoma cell proliferation: dominant role of PI-3′K/Akt signaling. Exp. Cell Res., 312, 1142-1152.
36. Resnicoff,M. et al. (1995) The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55, 2463-2469.
37. Kaleko,M. et al. (1990) Overexpression of the human insulin like growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol. Cell. Biol., 10, 464-473.
38. Cantarini,M.C. et al. (2006) Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology, 44, 446-457.
39. Desbois-Mouthon,C. et al. (2009) Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma. Clin. Cancer Res., 15, 5445-5456.
40. Polesskaya,A. et al. (2007) Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Genes Dev., 21, 1125-1138.